-
-
-
-
-
Executive committee
-
-
-
-
-
-
-
-
-
-
Chair of the Executive Committee
Martin Fassnacht, MD
Head of the Division of Endocrinology and Diabetes
Department of Internal Medicine I
University Hospital Würzburg
Oberdürrbacherstr. 6
Würzburg, Germany
Martin Fassnacht is Professor of Internal Medicine and Endocrinology at the University of Würzburg. He is head of the Division of Endocrinology and Diabetes at the University Hospital Würzburg. The main interest of his clinical and translational research group is endocrine tumors with a special focus on adrenal tumors. He run(s) several clinical trials for patients with adrenocortical carcinoma and malignant pheochromocytoma and his translational group is adrenocortical tumorigenesis and drug targets for adrenocortical carcinoma.
Period in office: 2016-2021
Treasurer
Pr Guillaume Assié
Endocrine department, Cochin hospital, APHP, Paris
Institut Cochin, Inserm CNRS, Université de Paris
Paris, France
Guillaume Assié is professor of Endocrinology in Université de Paris, working in the Endocrine department of Cochin hospital in Paris. He is specialized in general Endocrinology, mainly Cushing syndromes, adrenal tumors, and pituitary diseases.
His research activity is mainly focused on bioinformatics, mainly working on the genomic alterations of endocrine tumors, including adrenal tumors.
Period in office: 2019-2022
Secretary
Henri Timmers, MD, PhD
Division of Endocrinology
Department of Internal Medicine
Radboud University Medical Centre
Geert Grooteplein Zuid 8
Radboud, The Netherlands
Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.
Period in office: 2019-2022